Yonalink

Company Overview

Snapshot

Founded in June 2018 by Iddo Peleg and Gav Martell, Yonalink operates with 11–50 employees. The company secured $7.6M in total capital across four funding rounds from three investors. In May 2026, Yonalink was acquired by Veeva.

Business overview

Yonalink provides data management solutions for clinical trials, focusing on securely automating the transfer of patient data from electronic health records to electronic data capture systems. Its SaaS solution aims to enhance the speed, quality, and efficiency of clinical trial operations by simplifying data collection and validation. The company serves the Health Tech & Life Sciences sector, specifically within Digital Healthcare and Clinical Workflow, targeting healthcare providers and pharmaceutical companies in North America and Europe.

Strategic signal

Yonalink's acquisition by Veeva in May 2026 signals a significant validation of its AI platform for automating clinical trial data transfer. This move indicates a growing industry demand for streamlined, secure data integration in clinical research, positioning Yonalink's technology to potentially expand its impact within Veeva's broader ecosystem and accelerate innovation in clinical data management.

Company Intelligence Q&A

What was a significant recent corporate development for Yonalink?

In May 2026, Yonalink was acquired by Veeva, a multinational technology company, marking a key milestone for the company.

When did Yonalink last raise a funding round?

In November 2022, Yonalink raised a funding round from investors including Debiopharm Innovation Fund and eHealth Ventures.

Which organization selected Yonalink's platform for clinical trial integration?

In March 2023, Hadassah selected Yonalink's EHR-to-EDC clinical trial platform to integrate clinical care and research data.

What was the amount of the grant received from the Israel Innovation Authority?

In May 2020, Yonalink received a grant of $500,000 from the Israel Innovation Authority.